Extended diagnostic value of autologous serum skin test and basophil CD63 expression assay in chronic urticaria by Irinyi, Beatrix et al.
These articles have been accepted for publication in the British Journal of Dermatology and 
are currently being edited and typeset. Readers should note that articles published below have 
been fully refereed, but have not been through the copy-editing and proof correction process. 
Wiley-Blackwell and the British Association of Dermatologists cannot be held responsible 
for errors or consequences arising from the use of information contained in these articles; nor 
do the views and opinions expressed necessarily reflect those of Wiley-Blackwell or the 
British Association of Dermatologists 
 
 
 
Accepted Date : 20-Jul-2012 
Article type      : Item of Correspondence 
 
Extended diagnostic value of autologous serum skin test and basophil CD63 expression assay 
in chronic urticaria 
 
Running head: Diagnostic value of functional tests in chronic urticaria 
B. Irinyi1,2*, E. Gyimesi3*, E. Garaczi4, Zs. Bata4, L. Kemény4, M. Zeher3, E. Remenyik1, A. 
Szegedi1,2 
 
*Both authors contributed equally to this work.  
 
Departments of 1Dermatology, 2Dermatological Allergology, 3Division of Clinical 
Immunology in 3rd Department of Internal Medicine, University of Debrecen, Medical and 
Health Science Center, Debrecen, 4Department of Dermatology and Allergology, University 
of Szeged, Albert Szent-Györgyi Medical and Pharmaceutical Center, Szeged, Hungary 
 
Correspondence: 
Edit Gyimesi, PhD 
Móricz Zs str. 22, Debrecen, 4032 Hungary 
Tel./Fax: 36-52-255218 
E-mail: egyimesi@freemail.hu 
 
Funding sources 
This work was supported by Hungarian Research Grants (OTKA K81381, TÁMOP 4.2.2/B-
10/1-2010-0024). 
 
Conflict of interest 
All authors have declared that they have no conflict of interest. 
 
  
 
MADAM, Chronic urticaria (CU) is characterised by the occurrence of widespread, short-
lived weals, appearing daily or almost daily for at least 6 weeks. 1 There has been strong 
evidence supporting an autoimmune basis of the disease in approximately 27-50% of CU 
patients, who have functional autoantibodies against the high affinity IgE receptor and/or IgE. 
1 A correct diagnosis of autoimmune CU (ACU) is difficult but important because of the 
presence of more severe clinical symptoms. Currently, autologous serum skin test (ASST) 
serves as a screening method, after which more adequate confirmation is gained through 
functional assays, to identify the ACU group. 2 The basophil histamine release assay and flow 
cytometric basophil activation tests (BAT) are considered to be the gold standards; however, 
these tests are not accessible on an outpatient basis. 3,4 ASST is normally performed using 
undiluted autologous patient sera. 5 To avoid non-specific results in ASST, a 1 : 10 serum 
dilution has been suggested. 6 Our goal was to investigate whether ASST using diluted 
instead of undiluted sera would enhance specificity and to detect any correlation between the 
degree of basophil CD63 expression and clinical severity of the ACU. 
We recruited 46 patients with chronic spontaneous urticaria (CU) [mean durations of 
hives of 32·4 (2-189) months]. The ASST with undiluted sera 5 and BAT detecting basophil 
CD63 expression 7 were conducted on all patients and on ten nonatopic healthy controls as 
described.  Controls were negative in both tests [CD63: median: 2·72%, IQR (25-75%): 
4·260-5·755%]. ASST was also performed by using 1 : 10 and 1 : 100 diluted CU sera in CU 
patients. The urticaria score that was introduced by Breneman et al. 8 was recorded at the time 
of performing the ASST to assess disease severity (mean total urticaria score index: 10·22 ± 
2·39). Correlations between the two methods, the BAT and the ASST performed with 
undiluted, 1 : 10 and 1 : 100 diluted autologous patient sera were detected.  
 
 
  
 
Out of 46 patients, 34 showed positive ASST using undiluted sera and 30 were 
regarded as ACU on the basis of CD63 positivity. The statistical analyses demonstrated a 
significant positive correlation and moderate concordance between the undiluted ASST and 
BAT (Fig 1a). There were 2 nonspecific negative ASST cases and 6 ASST positive cases 
with unidentified autoreactivity among the patients when undiluted sera were used. 
The 1 : 10 dilution of sera reduced the number of nonspecific positives from 6 to 3, but 
nonspecific negative results increased dramatically from 2 to 20. The concordance between 
ASST and CD63 positivity was fair (Fig. 1b), and further decreased to poor by using 1 : 100 
diluted sera (Fig. 1c). There were no correlations between the BAT and ASST using diluted 
patient sera. ASST using undiluted sera showed 93·23% sensitivity and 62·5% specificity, 
which were calculated using the BAT as a reference. Although the specificity of ASST 
increased with rising serum dilutions, all of the other diagnostic performance parameters 
(sensitivity, lilelihood ratios, predictive values) changed unfavourably. As a consequence of 
these results, we conclude that conducting ASST with 1 : 10 or 1 : 100 diluted patient sera 
does not aid in the diagnosis of ACU. In the meantime, ACU patients (CD63+) with positive 
ASST at a 1 : 10 serum dilution showed significantly higher mean total urticaria scores 
compared with those (CD63+) with negative ASST at the same dilution (Fig. 2a). There was 
also a significant correlation between the mean total urticaria score index and rate of CD63 
positivity in the investigated ACU patients (Fig. 2b). These findings support the utility of 
ASST uing 1 : 10 diluted sera and the degree of CD63 cell surface expression in the 
measurement of ACU severity.  
In spite of some non-specific results in ASST, it is still the most practical screening 
test in the diagnosis of ACU. This is also the reason why attempts have been made to enhance 
the diagnostic value of this method. When the use of plasma was compared to that of serum, 
  
the plasma was not recommended because serum showed higher sensitivity, although they 
shared similar specificities. 9 In concordance with our results, Godse 10 analysed the effects of 
serum dilution in ASST on a limited number of patients and found that ASST using undiluted 
sera was more reliable than diluted sera for the diagnosis of ACU. However, this result was 
not confirmed by a functional test. 
  In summary, we have validated for the first time on a larger study group by comparing 
the ASST with the gold standard BAT that for the diagnosis of ACU, ASST using diluted 
autologous sera does not provide any incremental information. However, both ASST with 1 : 
10 diluted sera and the degree of CD63 cell surface expression can be used for determining 
ACU severity.   
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FIGURE LEGENDS 
Figure 1. Effect of serum dilution on autologous serum skin test (ASST) performance 
compared with flow cytometric basophil CD63 expression test (BAT) 
Autologous sera that were obtained from 46 chronic urticaria patients were used in differing 
dilutions for ASST and in the undiluted form for the BAT (as shown at the top of Fig 1. A: 1 : 
1; B: 1 : 10; C: 1 : 100). Horizontal dashed lines represent the cut-off value of 7·175 for 
basophil CD63 expression that was determined by ROC analysis. A. A significant positive 
correlation (Spearman’s rank correlation; r = 0·544, P < 0·001, not shown) and moderate 
concordance between the undiluted ASST and BAT have been found (Cohen’s Kappa test:  
kappa = 0·593; P < 0·001). B, C. With increasing serum dilutions for ASST, the concordance 
notably decreased between the ASST and CD63 test; at the same time, the number of 
nonspecific negative cases that was detected by ASST was shown to be enhanced.  
 
Figure 2.  Association of urticaria score with ASST positivity using 1 : 10 diluted ACU 
sera and correlation between basophil CD63 (BAT) expression and urticaria score in 
ACU patients 
A. ASST were performed using 1 : 10 diluted ACU sera on patients who had autoimmune 
chronic urticaria based on their positive results from the BAT. The mean total urticaria score 
was significantly elevated in the ASST+ patients group compared with the ASST– group 
(Student’s t-test, P = 0·020). B. A significant correlation between the degree of CD63 
positivity and mean total urticaria score index was found in patients with ACU with undiluted 
sera (n = 30, Spearman’s rank correlation; r = 0·438; P = 0·016). 
ASST – autologous serum skin test; ACU – autoimmune chronic urticaria  
  
  
 
 
 
 
